Annual Drug Patent Expirations for SELZENTRY
Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in SELZENTRY is maraviroc. Two suppliers are listed for this compound. Additional details are available on the maraviroc profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published at New patent expiration for Viiv Hlthcare drug SELZENTRY
You must log in to post a comment.